Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00536042 · ClinicalTrials.gov registry record · Phase 2
Open-Label Trial of the Use of Minocycline in the Treatment of Asthma
A Phase 2 study, sponsored by State University of New York - Downstate Medical Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 14
- Enrollment target
NCT00536042 is a Phase 2 study that has completed, run by State University of New York - Downstate Medical Center. The registered enrollment target is 14 participants.
The verdict
NCT00536042, a Phase 2 study, has completed, sponsored by State University of New York - Downstate Medical Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 14 participants
- Enrollment target
Study Summary
The tetracycline minocycline has, in addition to its anti-infective properties, anti-inflammatory properties which may be of use in the treatment of asthma. This study evaluates the benefit of minocycline as add-on therapy for adults with asthma.
Interventions
- DRUG Minocycline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 1997-10 |
| Est. Completion | 2009-06 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00536042
The ClinicalTrials.gov registry entry for NCT00536042 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is State University of New York - Downstate Medical Center, which has 18 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Minocycline is the first listed.
NCT00536042 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00536042 about?
NCT00536042 is a clinical study titled "Open-Label Trial of the Use of Minocycline in the Treatment of Asthma". The tetracycline minocycline has, in addition to its anti-infective properties, anti-inflammatory properties which may be of use in the treatment of asthma. This study evaluates the benefit of minocycline as add-on therapy for adults with asthma.
What is the current status of trial NCT00536042?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 14 participants. The study started on 1997-10. Estimated completion is 2009-06.
What interventions are being tested in trial NCT00536042?
The interventions under investigation include: Minocycline (DRUG).
Who is sponsoring clinical trial NCT00536042?
This trial is sponsored by State University of New York - Downstate Medical Center, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.